NCT05592990: An ongoing trial by Novartis Pharmaceuticals
This trial is ongoing. It must report results 10 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05592990 |
|---|---|
| Title | A Two Part, Randomized, Participant and Investigator-blinded, 2-arm, Parallel-design, Placebo-controlled Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of NGI226 Microparticles on Tendon Regeneration in Patients With Achilles Tendinopathy |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | June 14, 2023 |
| Completion date | Feb. 3, 2026 |
| Required reporting date | Feb. 3, 2027, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | March 26, 2026 |
| Days late | None |